Pharma & Biotech

Investors in French vaccine developer Valneva have experienced a period of extreme volatility, witnessing both significant setbacks and encouraging developments...

BioNTech has achieved a critical milestone in its oncology program, marking a significant advancement beyond its COVID-19 vaccine business. The...

While its high-profile legal battle with Apple Inc. continues to generate headlines, medical technology firm Masimo is simultaneously drawing significant...

Inari Medical Inc. and several of its former executives are mounting a vigorous defense against a class action lawsuit filed...

While 89bio continues to advance its key Phase 3 trial for its flagship drug candidate, Pegozafermin, the company has received...

Eli Lilly has generated significant attention in oncology circles following the FDA's decision to grant its lung cancer treatment Olomorasib...

BioNTech SE has achieved a significant milestone in its oncology pipeline, sending its stock price sharply higher. The Mainz-based biotechnology...

Shares of Rapid Micro Biosystems have staged an impressive three-day rally, defying conventional market logic after the company reported disappointing...

The investment case for Edwards Lifesciences presents a fascinating dichotomy as the company strengthens its strategic position while facing concerning...

Northwest Biotherapeutics shares closed lower for the fourth straight trading day, declining by 3.42% to settle at $0.251. The session...